Eli Lilly and Company
@EliLillyandCo
Uniting caring with discovery to create medicines that make life better worldwide. Lilly’s official account (formerly LillyPad)
加入 July 2010
1.2K 正在關注 146.3K 粉絲
Obesity raises the risk of type 2 diabetes and cardiovascular disease. A post-hoc analysis showed our oral obesity medicine was associated with reductions in the predicted risk of both conditions, with reductions seen across all doses. Read more:
顯示更多
